Diagnosed July 2022 w/IGA Lambda Free Light Chain Myeloma. I am 70yrs old. Currently in a Clinical Trial (MomenTal-6) through Nebraska Medical: Buffet Cancer Center. I started 2 bi-specifics Talquetamab and Teclistamab and Dexamethasone in combination on Aug 18, 2025. I was taken off Revlimid/Daratumamab/Dexamethasone July 2025 as it was not as effective anymore as when I was first diagnosed. I never reached remission. I have a comorbidity of cardiomyopathy. Not eligible for SCT or CarT. Would love to connect with anyone else on these bi-specifics especially regarding side effects etc.